NanoVibronix Inc. (NAOV) |
|
2.06 0.02 (0.98%)
|
09-23 14:53 |
|
Open: |
2.04 |
Pre. Close: |
2.04 |
|
High:
|
2.12 |
Low:
|
2.0101 |
|
Volume:
|
1,332,164 |
Market Cap:
|
50M |
|
|
|
|
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Elmsford, New York and currently employs 8 full-time employees. The firm's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The firm's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The firm operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The firm's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.162 - 2.172 |
2.172 - 2.182 |
|
Low:
|
1.937 - 1.948 |
1.948 - 1.958 |
|
Close:
|
2.043 - 2.061 |
2.061 - 2.076 |
|
Technical analysis |
as of: 2021-09-23 2:43:01 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 3.23  One year: 3.82 |
| Support: |
Support1: 1.94 Support2: 1.61 |
| Resistance: |
Resistance1: 2.76 Resistance2: 3.27 |
| Pivot: |
2.25 |
| Moving Average: |
MA(5): 2.06 MA(20): 2.43
MA(100): 1.54  MA(250): 1.19 |
| MACD: |
MACD(12,26): -0.10 Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 8.40 %D(3): 8.50 |
| RSI: |
RSI(14): 43.51 |
| 52-week: |
High: 4.19 Low: 0.54 Change(%): 136.9 |
| Average Vol(K): |
3-Month: 127158040 10-Days: 221535 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.NAOV has closed above bottom band by 23.2%. Bollinger Bands are 6.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 20 Sep 2021
NanoVibronix (NAOV) falls 8.37% to Close at $1.97 on September 20 - Equities.com
Thu, 16 Sep 2021
Premarket Mover: NanoVibronix Inc (NAOV) Down 1.79% - InvestorsObserver
Wed, 15 Sep 2021
NanoVibronix (NAOV) rose 11.44% in Light Trading on September 15 - Equities.com
Tue, 14 Sep 2021
NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS - GlobeNewswire
Wed, 08 Sep 2021
Is NanoVibronix Inc (NAOV) a Good Buy in the Medical Devices Industry? - InvestorsObserver
Thu, 02 Sep 2021
NAOV: Up More Than 200% in the Past Three Months, is NanoVibronix Still a Buy? - StockNews.com
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
24 |
| Shares Float (M) |
24 |
|
% Held by Insiders
|
12.15 |
|
% Held by Institutions
|
6.58 |
|
Shares Short (K)
|
4,180 |
|
Shares Short P. Month (K)
|
206 |
Stock Financials |
|
EPS
|
-0.573 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.170 |
|
Profit Margin
|
|
|
Operating Margin
|
-703.33 |
|
Return on Assets (ttm)
|
-74.1 |
|
Return on Equity (ttm)
|
-417.8 |
|
Qtrly Rev. Growth
|
18.2 |
|
Gross Profit (p.s.)
|
0.009 |
|
Sales Per Share
|
0.027 |
|
EBITDA (p.s.)
|
-0.193 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-5 |
|
Levered Free Cash Flow (M)
|
-4 |
Stock Valuations |
|
PE Ratio
|
-3.56 |
|
PEG Ratio
|
|
|
Price to Book value
|
12.00 |
|
Price to Sales
|
74.41 |
|
Price to Cash Flow
|
-10.08 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
